Novozymes A/S Dividend yield

 Price  463.00
 Dividend  5.51
 Earnings  12.97
 Cash-flow  15.13
 Book value  44.10
 Equity  42.95

Novozymes A/S is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Novozymes A/S is a company from Denmark, and his stocks are publicly traded.

Novozymes A/S paid a total dividend of 1,223 million DKK last year, for a market value of 102,786 millions (Market Cap 91,811 millions). Dividend per share of Novozymes A/S is 5.51 DKK, and his stock market price 463.00 DKK.

According to the chart below, where dividend yield is displayed, Novozymes A/S has a dividend yield of 1.19%, lower than the amount offered by both the market average and companies from Denmark. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Novozymes A/S dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Denmark.

Dividend yield of Novozymes A/S

Novozymes A/S Dividend Payout

About the ability of Novozymes A/S to maintain his current dividend of DKK 5.51 per share, an amount that accounts for 1.19%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Novozymes A/S payout on ernings is currently 42.48%, which is higher than the market average, and companies of Health Care industry, which are 38.25% and 29.07% respectively. Both figures show that Novozymes A/S can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Novozymes A/S is DKK 15.13 per share, which is higher than the dividend per share paid by the company of DKK 5.51, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Novozymes A/S, compared againt world market average, Denmark companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Novozymes A/S payout

Novozymes A/S Dividend History

Year Yield  DKK  Paypout  Shares* 

*In millions

Novozymes A/S Stock performance

Finally, last moth Novozymes A/S showed a return of 6.40% compared to a worldwide 1.12% average, and a 1.32% of Health Care firms. Over the last year, the company obtained a 14.00% versus a worldwide performance of a 5.73%. More detailed information can be seen in the following graph for Denmark and Pharmaceuticals and Biotechnology firms.

Novozymes A/S stock and market return